Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 2
2017 1
2020 1
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
A Chemically Defined TLR3 Agonist with Anticancer Activity.
Le Naour J, Thierry S, Scuderi SA, Boucard-Jourdin M, Liu P, Bonnin M, Pan Y, Perret C, Zhao L, Mao M, Renoux C, Pérez-Lanzón M, Martin B, Kepp O, Kroemer G, Werlé B. Le Naour J, et al. Among authors: boucard jourdin m. Oncoimmunology. 2023 Jun 27;12(1):2227510. doi: 10.1080/2162402X.2023.2227510. eCollection 2023. Oncoimmunology. 2023. PMID: 37389102 Free PMC article.
αvβ8 integrin-expression by BATF3-dependent dendritic cells facilitates early IgA responses to Rotavirus.
Nakawesi J, This S, Hütter J, Boucard-Jourdin M, Barateau V, Muleta KG, Gooday LJ, Thomsen KF, López AG, Ulmert I, Poncet D, Malissen B, Greenberg H, Thaunat O, Defrance T, Paidassi H, Lahl K. Nakawesi J, et al. Among authors: boucard jourdin m. Mucosal Immunol. 2021 Jan;14(1):53-67. doi: 10.1038/s41385-020-0276-8. Epub 2020 Mar 11. Mucosal Immunol. 2021. PMID: 32161355 Free article.
TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization.
Thierry S, Maadadi S, Berton A, Dimier L, Perret C, Vey N, Ourfali S, Saccas M, Caron S, Boucard-Jourdin M, Colombel M, Werle B, Bonnin M. Thierry S, et al. Among authors: boucard jourdin m. Microb Cell. 2023 Apr 19;10(6):117-132. doi: 10.15698/mic2023.06.797. eCollection 2023 Jun 5. Microb Cell. 2023. PMID: 37275475 Free PMC article.
Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis.
Asnagli H, Martire D, Belmonte N, Quentin J, Bastian H, Boucard-Jourdin M, Fall PB, Mausset-Bonnefont AL, Mantello-Moreau A, Rouquier S, Marchetti I, Jorgensen C, Foussat A, Louis-Plence P. Asnagli H, et al. Among authors: boucard jourdin m. Arthritis Res Ther. 2014 May 22;16(3):R115. doi: 10.1186/ar4567. Arthritis Res Ther. 2014. PMID: 24886976 Free PMC article.